Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (121-130 of 426) with videos related to

Pageof 43
Sort By:
Immunology|July 1, 1987
Antibody-dependent cytotoxicity on chicken red blood cell targets mediated by the U937 cell lineM B Villiers, R H Ward, P J Lachmann
Current Treatment Options in Neurology|September 4, 2018
Cryopyrin-Associated Periodic Fever Syndrome and the Nervous SystemStephen Keddie, Thomas Parker, Helen J Lachmann, et al.
Kidney International|December 4, 2014
Emerging treatments for amyloidosisRabya H Sayed, Philip N Hawkins, Helen J Lachmann
Ciba Foundation Symposium|January 1, 1986
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animalsP J Lachmann, L Strangeways, A Vyakarnam, et al.
Clinical and Experimental Immunology|February 1, 1990
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitationP A Gatenby, J E Barbosa, P J Lachmann
Clinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J Lachmann
Immunology|December 1, 1976
Purification of cobra venom factor from phospholipase A contaminantP J Lachmann, L Halbwachs, A Gewurz, et al.
Journal of Immunogenetics|December 1, 1977
Linkage studies with C6M J Hobart, P J Cook, P J Lachmann
Scandinavian Journal of Immunology|January 1, 1976
A mechanism of migration inhibition involving components of the coagulation systemC J Meade, P J Lachmann, R M Binns
Immunology|April 1, 1984
Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cellsD Y Sia, P J Lachmann, K N Leung
Pageof 43

Showing results (121-130 of 426) with videos related to

Sort By:
Pageof 43
Immunology|July 1, 1987
Antibody-dependent cytotoxicity on chicken red blood cell targets mediated by the U937 cell lineM B Villiers, R H Ward, P J Lachmann
Current Treatment Options in Neurology|September 4, 2018
Cryopyrin-Associated Periodic Fever Syndrome and the Nervous SystemStephen Keddie, Thomas Parker, Helen J Lachmann, et al.
Kidney International|December 4, 2014
Emerging treatments for amyloidosisRabya H Sayed, Philip N Hawkins, Helen J Lachmann
Ciba Foundation Symposium|January 1, 1986
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animalsP J Lachmann, L Strangeways, A Vyakarnam, et al.
Clinical and Experimental Immunology|February 1, 1990
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitationP A Gatenby, J E Barbosa, P J Lachmann
Clinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J Lachmann
Immunology|December 1, 1976
Purification of cobra venom factor from phospholipase A contaminantP J Lachmann, L Halbwachs, A Gewurz, et al.
Journal of Immunogenetics|December 1, 1977
Linkage studies with C6M J Hobart, P J Cook, P J Lachmann
Scandinavian Journal of Immunology|January 1, 1976
A mechanism of migration inhibition involving components of the coagulation systemC J Meade, P J Lachmann, R M Binns
Immunology|April 1, 1984
Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cellsD Y Sia, P J Lachmann, K N Leung
Pageof 43